Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease

Though Parkinson’s disease (PD) clinical picture is generally dominated by motor impairment, non-motor symptoms, such as cognitive decline and gastrointestinal dysfunctions, may develop before motor symptoms and have major effects on quality of life. L-3,4-di-hydroxy-phenylalanine (Levodopa) is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez-Pardo, Paula, Broersen, Laus M., Kliest, Tessa, van Wijk, Nick, Attali, Amos, Garssen, Johan, Kraneveld, Aletta D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088190/
https://www.ncbi.nlm.nih.gov/pubmed/30127735
http://dx.doi.org/10.3389/fnagi.2018.00237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088190/
https://www.ncbi.nlm.nih.gov/pubmed/30127735
http://dx.doi.org/10.3389/fnagi.2018.00237

Ejemplares similares